These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22168393)

  • 1. The dock-and-lock method combines recombinant engineering with site-specific covalent conjugation to generate multifunctional structures.
    Rossi EA; Goldenberg DM; Chang CH
    Bioconjug Chem; 2012 Mar; 23(3):309-23. PubMed ID: 22168393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex and defined biostructures with the dock-and-lock method.
    Rossi EA; Goldenberg DM; Chang CH
    Trends Pharmacol Sci; 2012 Sep; 33(9):474-81. PubMed ID: 22739259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dock and lock method: a novel platform technology for building multivalent, multifunctional structures of defined composition with retained bioactivity.
    Chang CH; Rossi EA; Goldenberg DM
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5586s-5591s. PubMed ID: 17875793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new method to produce monoPEGylated dimeric cytokines shown with human interferon-α2b.
    Chang CH; Rossi EA; Cardillo TM; Nordstrom DL; McBride WJ; Goldenberg DM
    Bioconjug Chem; 2009 Oct; 20(10):1899-907. PubMed ID: 19736932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of multivalent bispecific antibodies and immunocytokines with improved in vivo properties.
    Rossi EA; Chang CH; Cardillo TM; Goldenberg DM
    Bioconjug Chem; 2013 Jan; 24(1):63-71. PubMed ID: 23116517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli.
    DeFrees S; Wang ZG; Xing R; Scott AE; Wang J; Zopf D; Gouty DL; Sjoberg ER; Panneerselvam K; Brinkman-Van der Linden EC; Bayer RJ; Tarp MA; Clausen H
    Glycobiology; 2006 Sep; 16(9):833-43. PubMed ID: 16717104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of PEGylation and refolding for renaturation of recombinant proteins from insoluble aggregates produced in bacteria--application to a single-chain Fv fragment.
    Kumagai I; Asano R; Nakanishi T; Hashikami K; Tanaka S; Badran A; Sanada H; Umetsu M
    J Biosci Bioeng; 2010 May; 109(5):447-52. PubMed ID: 20347766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.
    Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S
    Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility.
    Albrecht H; Denardo GL; Denardo SJ
    J Immunol Methods; 2006 Mar; 310(1-2):100-16. PubMed ID: 16499921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional antibodies by the Dock-and-Lock method for improved cancer imaging and therapy by pretargeting.
    J Nucl Med; ; . PubMed ID: 18077530
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.